FDA's Advertising Studies Expand To Internet Spots, Disease Awareness

FDA is continuing to start new studies on the format of advertising even as it prepares to release the results from previous research. While the steady drip of studies gives industry continuing opportunity to provide feedback to the agency's Division of Drug Marketing, Advertising and Communications, it also means that the findings that FDA makes, particularly on the impact of qualitative language, may be superseded by further research.

More from Archive

More from Pink Sheet